• 1. West China School of Nursing, Sichuan University/West China Hospital, Sichuan University, Chengdu 610041, P. R. China;
  • 2. West China School of Nursing, Sichuan University/Department of Gastrointestinal Surgery, West China Hospital, Sichuan University, Chengdu 610041, P. R. China;
  • 3. West China School of Nursing, Sichuan University/Department of Surgery, West China Hospital, Sichuan University, Chengdu 610041, P. R. China;
GONG Renrong, Email: gongrenrong@163.com; LI Ka, Email: likalika127127@163.com
Export PDF Favorites Scan Get Citation

Objective To summarize the research status of intelligent patient monitoring and risk warning, and provide reference and enlightenment for promoting the construction of intelligent monitoring and management platform of clinical patient risk.Method The literatures about patient monitoring and risk warning at home and abroad in recent years were reviewed.Results At present, the research at home and abroad mainly focused on the retrospective construction of the prediction model of severe complications of inpatients by using the electronic medical record database. The clinical decision support system based on real-time vital signs and dynamic electronic medical record data was still in the early development stage, and there was no mature product with high market share.Conclusions The construction process of structured electronic medical record system should be further strengthened, and the fully integrated clinical decision support system and artificial intelligence self-learning system should be the key research and development direction in the future, so as to promote the deep integration of big data and artificial intelligence technology with clinical scenes.

Citation: LIANG Shiqi, LIU Yuwei, HE Yuhua, GONG Renrong, LI Ka. Research progress of patient intelligent monitoring and risk warning. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2021, 28(9): 1232-1236. doi: 10.7507/1007-9424.202011092 Copy

  • Previous Article

    甲状腺手术中甲状旁腺自体移植及体外保存
  • Next Article

    Advances in immunophenotyping of hepatocellular carcinoma